StockNews.com Begins Coverage on Syros Pharmaceuticals (NASDAQ:SYRS)
Research analysts at StockNews.com assumed coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the stock. Syros Pharmaceuticals Trading Up 12.1% NASDAQ:SYRS opened at $0.04 on Friday. The company’s 50-day moving average price is $0.04 and its 200-day moving […]
Research analysts at StockNews.com assumed coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the stock. Syros Pharmaceuticals Trading Up 12.1% NASDAQ:SYRS opened at $0.04 on Friday. The company’s 50-day moving average price is $0.04 and its 200-day moving […]
